MW 362.4 Da, Purity >99%. Potent, selective HDAC3 inhibitor (IC50 = 80 nM). Induces DNA damage, impaired S phase progression and apoptosis in tumor cell lines. Shows central effects in vivo. .
View Alternative Names
HD3, HDAC3_HUMAN, Histone deacetylase 3, RPD 3, RPD3-2, SMAP45
- Chemical Structure
Lab
Chemical Structure - RGFP 966, HDAC3 inhibitor (AB144819)
2D chemical structure image of ab144819, RGFP 966, HDAC3 inhibitor
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Publications (6)
Recent publications for all applications. Explore the full list and refine your search
Journal of translational medicine 23:609 PubMed40457335
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cells 12: PubMed37174649
2023
Applications
Unspecified application
Species
Unspecified reactive species
The EMBO journal 40:e106818 PubMed33909924
2021
Applications
Unspecified application
Species
Unspecified reactive species
Cell 176:182-197.e23 PubMed30595450
2019
Applications
Unspecified application
Species
Unspecified reactive species
Behavioural brain research 356:453-469 PubMed29860001
2018
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 5:16616 PubMed26577291
2015
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com